Keen Logo
KEEN Growth Capital’s vision is to transform food and health systems by replacing ineffective or harmful products with healthy foods, functional foods, evidence-based food as medicine and emergent food technologies.

Our 4 Areas of Focus

With diet related diseases as the number one risk for early mortality, what we are eating or not eating is directly linked to good health and well-being. With Fund I and II we planted our roots firmly in the better-for-you food and beverage space, and with the shift in consumer behavior, technological advancements, and growing health and wellness issues, we expanded our areas of focus to invest in key foods and supplements with validated outcomes and their innovative underlying technologies.

Healthy Foods

We invest in delicious nutrient-dense snacks and foods to impact the most lives possible through healthier options instead of foods with empty calories or even harmful products.
Functional Foods

We invest in foods and supplements that have a positive impact on health beyond basic nutrition. Clinically-proven foods that promote optimal health including fortified, enhanced and minimally processed whole foods.

Food as Medicine

We invest in evidence-based nutrition, using food and natural ingredients as the delivery system, with positive clinical outcomes that bridge the gap between traditional supplements and medications.

Food & Related Tech

We invest in emerging food technologies that are advancing food processing, biomarker measurement and data processing to deepen our understanding of what it means to be truly healthy and help transform our food and health systems.
ESG With Impact

We deliver impact in line with the United Nations Sustainable Development Goals


Get to Know Our Team

KEEN Growth Capital is led by passionate entrepreneurs and seasoned experts who have driven innovation from early stage companies through Fortune 500 brands. The team has a deep understanding of operational excellence and brings multifaceted functional knowledge to the portfolio brands. As investors, we have consistently produced venture returns well above market average.